Global Immunohistochemistry Market: Industry Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Immunohistochemistry (IHC) Market by Product (Antibodies (Primary antibodies and Secondary antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment), Kits (IHC Kits for Human tissue, IHC Kits for Animal tissue)), by Application (Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases), Research Applications (Drug development and Testing, Other research applications), Forensic applications), by End-user (Hospitals & Diagnostic Laboratories, Academic & research Institutes, Other end users)and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The Immunohistochemistry (IHC) market is valued at USD 1.9 billion in 2021 and is poised to grow at a significant CAGR of 9.2% over 2022–2028. Since personalized medicine has shown to be quite successful in treating non-small-cell lung cancer patients, its use is anticipated to rise. By providing the most thorough and precise histological subtyping of tumors feasible, immunohistochemistry techniques enable this method of treatment decision-making (supported by predictive immunohistochemistry and the assessment of relevant biomarkers). Additionally, the improved accessibility of immunohistochemical assays that identify mutant proteins (such as BRAF V600E and IDH1 R132H) offers a useful substitute or supplementary method to molecular testing. These methods are valuable novel tools in contemporary cancer care since they are highly reproducible, involve a manageable level of technical and interpretative complexity, and are accessible for comparatively little money. Furthermore, multiplex and mutation-specific immunohistochemistry tests are significant advances that have boosted value in targeted therapy and personalized medicine. The demand for IHC in disease diagnosis has increased significantly due to improvements in IHC methods. The market is growing due to the rise in product approvals and the introduction of technologically sophisticated IHC equipment for illness diagnostics. For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify patients with dMMR solid tumors who are candidates for anti-PD-1 immunotherapy. To improve their market position, businesses keep releasing innovative items which generate income. For instance, in March 2021, Roche introduced the DISCOVERY Green HRP kit to find and characterize cell populations and biomarkers in tissue-based research. The multiplexing capabilities of in situ hybridization and IHC can be increased by using this kit in conjunction with other detection kits. The leading players are launching new products, merging with other companies, expanding regionally, and engaging in other strategic efforts in the field of IHC to address the growing demand for IHC assays in cancer diagnostics. For instance, Biocare Medical LLC introduced the ONCORE Pro in January 2021. This benchtop in vitro diagnostic system is fully automated and is used for In-situ Hybridization (ISH) and IHC applications.

Recent Market Developments:

In August 2021, Roche received FDA approval for VENTANA MMR RxDx companion diagnostic test based on immunohistochemistry for solid tumors that are deficient in the MMR pathway. The test identifies patients eligible for GSK’s anti-PD1 immunotherapy, JEMPERLI.

Immunohistochemistry Market

MARKET SUMMARY
-
9.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 9.2%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Immunohistochemistry Market

  • The report on global immunohistochemistry market gives historical, current and future market sizes (US$ Bn) based on the product type, application, end user and region.
  • Immunohistochemistry Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Danaher Corporation
  • Perkinelmer, Inc.
Immunohistochemistry Market Growth

The aging population will benefit the growth of the IHC market in both established and developing regions. The prevalence of age-related disorders is anticipated to rise dramatically with the worldwide geriatric population’s rapid growth. In 2019, there were 54 million senior persons living in the US, according to the OECD. Other wealthy nations have sizable and expanding geriatric populations as well. The chance of contracting diseases rises proportionately with age. Therefore, it is anticipated that the prevalence of various diseases will increase globally as the senior population grows. This is considered a significant element are propelling the IHC market for diagnostic applications. On the other hand, immunohistochemistry is expected to have a slow development rate due to the low specificity of IHC techniques and their expensive setup costs.


North-America Got Significant Share

Immunohistochemistry Market

The Immunohistochemistry (IHC) market in North America is likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly. Major market companies' presence, the simplicity of obtaining IHC solutions, the increased use of technologically improved IHC equipment, and the arrival of newer IHC solutions are essential aspects influencing the growth of the North American market. The CAGR for the Asia Pacific is anticipated to be the fastest during the projection period. This is mainly because the global players' geographic reach has increased in the Asian markets. Additionally, a sizable patient base in nations like China and India supplies a lot of clinical subjects for IHC R&D tests, which boosts sales.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The immunohistochemistry market report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Immunohistochemistry Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The immunohistochemistry market is projected to expand at a CAGR of 9.2% during the forecast period.

Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, Perkinelmer, Inc., Bio-Rad Laboratories, Inc.

North America is the fastest-growing region for immunohistochemistry market


Report

Table Of Content

  1. Table of Content
    1. Executive Summary
    2. Global Immunohistochemistry Market Introduction
      • Global Immunohistochemistry Market – Taxonomy
      • Global Immunohistochemistry Market –Definitions
        • Product Type
        • Application
        • End User
    1. Global Immunohistochemistry Market Dynamics
      • Drivers
      • Restraints
      • Opportunities/Unmet Needs of the Market
      • Trends
      • Global Immunohistochemistry Market Dynamic Factors – Impact Analysis
      • Global Immunohistochemistry Market – Competition Landscape
    2. Global Immunohistochemistry Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Market Opportunity Analysis
    3. Global Immunohistochemistry Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Antibodies
        • Primary Antibodies
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Secondary Antibodies
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Equipment
          • Tissue Microarrays
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Tissue Processing Systems
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Slide Scanners
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Others
            • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Reagents
            • Histological Stains
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Blocking Sera and Reagents
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Chromogenic Substrates
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Fixation Reagents
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Stabilizers
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Organic Solvents
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Proteolytic Enzymes
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Diluents
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
            • Kits
              • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
              • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
              • Market Opportunity Analysis
    1. Global Immunohistochemistry Market, By Application, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Diagnostics
        • Cancer
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Infectious Diseases
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Cardiovascular Diseases
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Autoimmune Diseases
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Diabetes Mellitus
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Nephrological Diseases
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Drug Testing
          • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
    1. Global Immunohistochemistry Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Hospitals and Diagnostic Laboratories
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Research Institutes
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Immunohistochemistry Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • North America
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Europe
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Asia-Pacific
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Latin America
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Middle East and Africa
        • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Global Immunohistochemistry Market – Opportunity Analysis Index, By Product Type, Application, End User, and Region, 2020 – 2026
    2. North America Immunohistochemistry Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Antibodies
          • Primary Antibodies
          • Secondary Antibodies
        • Equipment
          • Tissue Microarrays
          • Tissue Processing Systems
          • Slide Scanners
          • Others
        • Reagents
          • Histological Stains
          • Blocking Sera and Reagents
          • Chromogenic Substrates
          • Fixation Reagents
          • Stabilizers
          • Organic Solvents
          • Proteolytic Enzymes
          • Diluents
        • Kits
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Diagnostics
          • Cancer
          • Infectious Diseases
          • Cardiovascular Diseases
          • Autoimmune Diseases
          • Diabetes Mellitus
          • Nephrological Diseases
        • Drug Testing
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Diagnostic Laboratories
        • Research Institutes
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • S.
        • Canada
      • North America Immunohistochemistry Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2020 – 2026
      • North America Immunohistochemistry Market Dynamics – Trends
    3. Europe Immunohistochemistry Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Antibodies
          • Primary Antibodies
          • Secondary Antibodies
        • Equipment
          • Tissue Microarrays
          • Tissue Processing Systems
          • Slide Scanners
          • Others
        • Reagents
          • Histological Stains
          • Blocking Sera and Reagents
          • Chromogenic Substrates
          • Fixation Reagents
          • Stabilizers
          • Organic Solvents
          • Proteolytic Enzymes
          • Diluents
        • Kits
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Diagnostics
          • Cancer
          • Infectious Diseases
          • Cardiovascular Diseases
          • Autoimmune Diseases
          • Diabetes Mellitus
          • Nephrological Diseases
        • Drug Testing
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Diagnostic Laboratories
        • Research Institutes
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Immunohistochemistry Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2020 – 2026
      • Europe Immunohistochemistry Market Dynamics – Trends
    4. Asia-Pacific Immunohistochemistry Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Antibodies
          • Primary Antibodies
          • Secondary Antibodies
        • Equipment
          • Tissue Microarrays
          • Tissue Processing Systems
          • Slide Scanners
          • Others
        • Reagents
          • Histological Stains
          • Blocking Sera and Reagents
          • Chromogenic Substrates
          • Fixation Reagents
          • Stabilizers
          • Organic Solvents
          • Proteolytic Enzymes
          • Diluents
        • Kits
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Diagnostics
          • Cancer
          • Infectious Diseases
          • Cardiovascular Diseases
          • Autoimmune Diseases
          • Diabetes Mellitus
          • Nephrological Diseases
        • Drug Testing
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Diagnostic Laboratories
        • Research Institutes
        • Others
      • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Immunohistochemistry Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2020 – 2026
      • Asia-Pacific Immunohistochemistry Market Dynamics – Trends
    5. Latin America Immunohistochemistry Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Antibodies
          • Primary Antibodies
          • Secondary Antibodies
        • Equipment
          • Tissue Microarrays
          • Tissue Processing Systems
          • Slide Scanners
          • Others
        • Reagents
          • Histological Stains
          • Blocking Sera and Reagents
          • Chromogenic Substrates
          • Fixation Reagents
          • Stabilizers
          • Organic Solvents
          • Proteolytic Enzymes
          • Diluents
        • Kits
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Diagnostics
          • Cancer
          • Infectious Diseases
          • Cardiovascular Diseases
          • Autoimmune Diseases
          • Diabetes Mellitus
          • Nephrological Diseases
        • Drug Testing
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Diagnostic Laboratories
        • Research Institutes
        • Others
      • Other DiseasesCountry Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Immunohistochemistry Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2020 – 2026
      • Latin America Immunohistochemistry Market Dynamics – Trends
    6. Middle East and Africa Immunohistochemistry Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Antibodies
          • Primary Antibodies
          • Secondary Antibodies
        • Equipment
          • Tissue Microarrays
          • Tissue Processing Systems
          • Slide Scanners
          • Others
        • Reagents
          • Histological Stains
          • Blocking Sera and Reagents
          • Chromogenic Substrates
          • Fixation Reagents
          • Stabilizers
          • Organic Solvents
          • Proteolytic Enzymes
          • Diluents
        • Kits
      • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Diagnostics
          • Cancer
          • Infectious Diseases
          • Cardiovascular Diseases
          • Autoimmune Diseases
          • Diabetes Mellitus
          • Nephrological Diseases
        • Drug Testing
      • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Diagnostic Laboratories
        • Research Institutes
        • Others
      • Other DiseasesCountry Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Immunohistochemistry Market – Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2020 – 2026
      • MEA Immunohistochemistry Market Dynamics – Trends
    7. Competition Landscape
      • Strategic Dashboard of Top Market Players
      • Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
        • Abbott Laboratories
        • Arrayit Corp.
        • Abnova
        • Biocare Medical
        • Biogenex
        • Cell Marque Corp.
        • Cell Signaling Technology inc.
        • Danaher Corp.
        • Diagnostic Biosystems Inc.
        • Hoffmann-La Roche AG
        • Histologix
        • Immunologic
        • Bio-Rad Laboratories Inc.
        • Perkinelmer Inc.
        • Thermo Fisher Scientific Inc.
        • Rockland Immunochemicals.
    1. Research Methodology
    2. Key Assumptions and Acronyms

Report

Company Profile

  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Danaher Corporation
  • Perkinelmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Bio SB
  • Agilent Technologies, Inc.
  • Abcam plc.

Description

The Immunohistochemistry (IHC) market is valued at USD 1.9 billion in 2021 and is poised to grow at a significant CAGR of 9.2% over 2022–2028. Since personalized medicine has shown to be quite successful in treating non-small-cell lung cancer patients, its use is anticipated to rise. By providing the most thorough and precise histological subtyping of tumors feasible, immunohistochemistry techniques enable this method of treatment decision-making (supported by predictive immunohistochemistry and the assessment of relevant biomarkers). Additionally, the improved accessibility of immunohistochemical assays that identify mutant proteins (such as BRAF V600E and IDH1 R132H) offers a useful substitute or supplementary method to molecular testing. These methods are valuable novel tools in contemporary cancer care since they are highly reproducible, involve a manageable level of technical and interpretative complexity, and are accessible for comparatively little money. Furthermore, multiplex and mutation-specific immunohistochemistry tests are significant advances that have boosted value in targeted therapy and personalized medicine. The demand for IHC in disease diagnosis has increased significantly due to improvements in IHC methods. The market is growing due to the rise in product approvals and the introduction of technologically sophisticated IHC equipment for illness diagnostics. For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify patients with dMMR solid tumors who are candidates for anti-PD-1 immunotherapy. To improve their market position, businesses keep releasing innovative items which generate income. For instance, in March 2021, Roche introduced the DISCOVERY Green HRP kit to find and characterize cell populations and biomarkers in tissue-based research. The multiplexing capabilities of in situ hybridization and IHC can be increased by using this kit in conjunction with other detection kits. The leading players are launching new products, merging with other companies, expanding regionally, and engaging in other strategic efforts in the field of IHC to address the growing demand for IHC assays in cancer diagnostics. For instance, Biocare Medical LLC introduced the ONCORE Pro in January 2021. This benchtop in vitro diagnostic system is fully automated and is used for In-situ Hybridization (ISH) and IHC applications.

Recent Market Developments:

In August 2021, Roche received FDA approval for VENTANA MMR RxDx companion diagnostic test based on immunohistochemistry for solid tumors that are deficient in the MMR pathway. The test identifies patients eligible for GSK’s anti-PD1 immunotherapy, JEMPERLI.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX